Tempest Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Tempest Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • Tempest Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 22.5M shares, a 59.9% increase year-over-year.
  • Tempest Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 15.4M shares, a 33.5% increase from 2022.
  • Tempest Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.5M shares, a 205% increase from 2021.
  • Tempest Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 3.79M shares, a 710% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 22.5M +8.44M +59.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 22.2M +8.47M +61.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 15.4M +3.87M +33.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 14.1M +486K +3.56% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 14.1M +2.53M +21.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 13.8M +6.6M +92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 11.5M +7.76M +205% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 13.6M +6.92M +103% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 11.6M +10.6M +1151% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 7.17M +6.66M +1312% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 3.79M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 6.72M +6.2M +1188% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 925K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 507K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 521K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.